BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 16217698)

  • 1. [Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)].
    Arendt G
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):577-86. PubMed ID: 16217698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly active antiretroviral therapy access and neurological complications of human immunodeficiency virus infection: impact versus resources in Brazil.
    Silva MT; Araújo A
    J Neurovirol; 2005; 11 Suppl 3():11-5. PubMed ID: 16540448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
    Sacktor N
    J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurological complications of HIV infection. Review: new diagnostic, therapeutic and prognostic aspects].
    Radziwill AJ; Kappos L; Battegay M; Steck AJ
    Schweiz Med Wochenschr; 2000 Apr; 130(13):457-70. PubMed ID: 10812641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurologic complications of HIV infection in the HAART era. Rapid and efficient diagnosis].
    Arendt G; Haslinger BA
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():66-9. PubMed ID: 15011596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuro-AIDS in the cART era].
    Arendt G; Nolting T
    Fortschr Neurol Psychiatr; 2012 Aug; 80(8):450-7. PubMed ID: 22895840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
    Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurological manifestations of the HIV infection].
    Arendt G; Nolting T
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():75-7. PubMed ID: 16385884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
    Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system disorders in AIDS.
    Levy RM; Bredesen DE; Rosenblum ML; Davis RL
    Immunol Ser; 1989; 44():371-401. PubMed ID: 2489119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Focal presentation of progressive multifocal leukoencephalopathy: first manifestation of human immunodeficiency virus infection].
    Martínez L; Cuesta J; Santos S; Tejero C
    Neurologia; 2008 Oct; 23(8):532-5. PubMed ID: 18392989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the neuropathology of HIV in the HAART era.
    Bell JE
    Histopathology; 2004 Dec; 45(6):549-59. PubMed ID: 15569045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
    Cingolani A; Fratino L; Scoppettuolo G; Antinori A
    J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era.
    Moroni M; Antinori S
    AIDS; 2003 Apr; 17 Suppl 1():S51-64. PubMed ID: 12870531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and dementia in older adults.
    Valcour V; Paul R
    Clin Infect Dis; 2006 May; 42(10):1449-54. PubMed ID: 16619159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
    Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
    J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological disease in patients with human immunodeficiency virus infection.
    Gane EJ; Ellis-Pegler RB; Thomas MG
    N Z Med J; 1992 Feb; 105(928):49-51. PubMed ID: 1542470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New features of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy and natalizumab.
    Lima MA; Koralnik IJ
    J Neurovirol; 2005; 11 Suppl 3():52-7. PubMed ID: 16540456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era.
    dos Santos Pinheiro R; França TT; Ribeiro CM; Leão JC; de Souza IP; Castro GF
    J Oral Pathol Med; 2009 Sep; 38(8):613-22. PubMed ID: 19614862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.